TY - JOUR
T1 - Prevalence of sars-cov-2 antibodies after first 6 months of COVID-19 pandemic, Portugal
AU - Castro, Luísa Canto e
AU - Pereira, Ana Helena Guia
AU - Ribeiro, Rita
AU - Alves, Catarina
AU - Veloso, Luís
AU - Vicente, Vera
AU - Alves, Dalila
AU - Domingues, Inês
AU - Silva, Cláudia
AU - Gomes, Andreia
AU - Serrano, Marta
AU - Afonso, Ângela
AU - Veldhoen, Marc
AU - Sousa, Maria José Rego de
AU - de Sousa, José Germano Rego
AU - de Sousa, Germano
AU - Mota, Maria M.
AU - Silva-Santos, Bruno
AU - Ribeiro, Ruy M.
N1 - Publisher Copyright:
© 2021 Centers for Disease Control and Prevention (CDC). All rights reserved.
PY - 2021/11
Y1 - 2021/11
N2 - In September 2020, we tested 13,398 persons in Portugal for antibodies against severe acute respiratory syndrome coronavirus 2 by using a quota sample stratifi ed by age and population density. We found a seroprevalence of 2.2%, 3-4 times larger than the offi cial number of cases at the end of the first wave of the pandemic.
AB - In September 2020, we tested 13,398 persons in Portugal for antibodies against severe acute respiratory syndrome coronavirus 2 by using a quota sample stratifi ed by age and population density. We found a seroprevalence of 2.2%, 3-4 times larger than the offi cial number of cases at the end of the first wave of the pandemic.
UR - http://www.scopus.com/inward/record.url?scp=85117882515&partnerID=8YFLogxK
U2 - 10.3201/eid2711.210636
DO - 10.3201/eid2711.210636
M3 - Article
C2 - 34437830
AN - SCOPUS:85117882515
SN - 1080-6040
VL - 27
SP - 2878
EP - 2881
JO - Emerging Infectious Diseases
JF - Emerging Infectious Diseases
IS - 11
ER -